However, the comparison of tumorigenic sensitivity to TALEN-mediated Trp53 mutant gene in the tumor susceptible FVB/NJ mice and resistant C57BL/6 mice have never been considered, although several comparative studies have compared the factors affecting cancer incidence in Trp53 deficient mice [14, 15]. Here, TP53 is linked to neoplasm.